InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Fickenscher James E, Chief Financial Officer. Insider active across 1 company, notably Zynerba Pharmaceuticals, Inc.. Cumulatively, 7 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €10k. History available since 26 January 2022. The latest transaction was filed on 23 January 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Fickenscher James E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
123,087 sharesCommon StockSEC:0001140361-23-047742:0
31,200 sharesCommon StockSEC:0001062993-23-018020:0
22,547 sharesCommon StockSEC:0000899243-23-004444:0
21,073 sharesCommon StockSEC:0000899243-23-003726:0
17,769 shares@ US$0.5978100.0% of flowCommon StockSEC:0001062993-23-001386:0
20,800 sharesCommon StockSEC:0001062993-22-016556:0
85,000 shares0Common StockSEC:0001062993-22-001785:0
7 of 7 declarations
About Fickenscher James E
James E. Fickenscher is the Chief Financial Officer at Zynerba Pharmaceuticals, Inc. In this role, he oversees the financial management of the company, ensuring compliance and efficiency in financial operations.
